Takeda’s diabetes therapy to see 10 generics soon

Ten generics of Takeda Pharmaceutical’s diabetes adjunct therapy Actos met (metformin hydrochloride, pioglitazone hydrochloride) are about to hit the domestic market with the termination of a priority sales right of KyungDong Pharm’s Pictomin generic. Ky http://www.koreabiomed.com/news/articleView.html?idxno=3633